These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16187431)

  • 1. Tough to treat. Diabetes and heart failure.
    Gottlieb SH
    Diabetes Forecast; 2005 Sep; 58(9):35-7. PubMed ID: 16187431
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.
    Masoudi FA; Inzucchi SE
    Am J Cardiol; 2007 Feb; 99(4A):113B-132B. PubMed ID: 17307064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with both diabetes and heart failure often treated with medications government considers unsafe.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Aug; 14(15):1, 6-7. PubMed ID: 12964577
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime.
    Leier CV; Haas GJ
    J Am Coll Cardiol; 2007 Jul; 50(1):37-9. PubMed ID: 17601543
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart failure and diabetes mellitus: epidemiology and management of an alarming association.
    Cohen-Solal A; Beauvais F; Logeart D
    J Card Fail; 2008 Sep; 14(7):615-25. PubMed ID: 18722328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control and treatment patterns in patients with heart failure.
    Tang WH
    Heart Fail Monit; 2006; 5(1):10-4. PubMed ID: 16547530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus and heart failure.
    Choy CK; Rodgers JE; Nappi JM; Haines ST
    Pharmacotherapy; 2008 Feb; 28(2):170-92. PubMed ID: 18225964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 10. The UGDP and the FDA audit.
    Am Fam Physician; 1979 Jul; 20(1):67. PubMed ID: 377929
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A patient with heart failure and a new murmur: not always a valvular problem].
    Vervoort G; van Deuren M
    Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1652; author reply 1652-3. PubMed ID: 16078775
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metformin. Contraindications in heart failure reconsidered].
    Schmitt-Hönl B
    Med Monatsschr Pharm; 2008 Apr; 31(4):148-9. PubMed ID: 18497248
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
    McCall KL; Craddock D; Edwards K
    Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes mellitus and heart failure: epidemiology and therapy].
    Pfister R; Erdmann E
    Herz; 2008 Apr; 33(3):178-83. PubMed ID: 18568311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of comorbid conditions in heart failure: a review.
    Nagarajan V; Tang WH
    Med Clin North Am; 2012 Sep; 96(5):975-85. PubMed ID: 22980059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in concomitant heart failure and depression.
    Parashar A; Varma A
    J Am Geriatr Soc; 2007 Aug; 55(8):1303; author reply 1303-4. PubMed ID: 17661975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.